Anti-N-methyl-D-aspartate receptor encephalitis induced by bilateral ovarian teratomas with distinct histopathologic types: A case report and brief literature review

Wenchen Li, Dan Jia, Lan Tong, Zhijun Lun, Hailiang Li, Wenchen Li, Dan Jia, Lan Tong, Zhijun Lun, Hailiang Li

Abstract

Rationale: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder that is most frequently induced by ovarian teratoma in young females. The condition can be controlled and reversed via ovarian tumor resection and immunotherapy. However, anti-NMDAR encephalitis induced by bilateral ovarian teratomas with distinct histopathologic types is rarely reported in the literature.

Patient concerns: A 23-year-old woman presented with seizures.

Diagnoses: The diagnosis was anti-NMDAR encephalitis associated with ovarian teratomas based on positive anti-NMDAR antibody tests in both the cerebrospinal fluid and serum, and the detection of bilateral ovarian lesions on pelvic computed tomography. The postoperative histopathologic examination confirmed that the left lesion was an immature teratoma, and the right lesion was a mature teratoma.

Interventions: We performed surgical resection of the ovarian teratomas and administered immunotherapy for the control of anti-NMDAR encephalitis. Chemotherapy was administered for the immature teratoma.

Outcomes: The patient recovered without any postoperative complications. She has been confirmed to be in complete clinical remission, and has not had a recurrence during 18 months of follow-up.

Lessons: Anti-NMDAR encephalitis induced by bilateral ovarian teratomas of differing histopathologic types (1 immature and 1 mature) is rare. Early diagnosis and treatment with tumor resection, immunotherapy, and chemotherapy are critical for a good prognosis.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Craniocerebral magnetic resonance imaging showing no abnormality.
Figure 2
Figure 2
Bilateral ovarian lesions (arrows). Left tumor, 5.4 × 3.2 cm; right tumor, 3.1 × 1.8 cm.
Figure 3
Figure 3
Pathologic examination of left ovarian teratoma. (A) Magnification, 4×. (B) Magnification, 40×.

References

    1. Dalmau J, Bataller L. Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications [in Spanish]. Neurologia 2007;22:526–37.
    1. Kang S, Park SY. To predict or not to predict? The dilemma of predicting the risk of suboptimal cytoreduction in ovarian cancer. Ann Oncol 2011;22:viii23–8.
    1. Zhang L, Wu MQ, Hao ZL, et al. Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: a systematic review of reported cases. Epilepsy Behav 2017;68:57–65.
    1. Acien P, Acien M, Ruiz-Macia E, et al. Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases. Orphanet J Rare Dis 2014;9:157.
    1. Dabner M, McCluggage WG, Bundell C, et al. Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 2012;31:429–37.
    1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–8.
    1. TY H, W Z, DF Z. Ovarian teratoma with anti-NMDAR encephalitis in 2 cases. J Prac Obste Gynecol 2016;32:378–1378.
    1. SN W, XX L, H L. A case of ovarian teratoma complicated with N-methyl-D-aspartate receptor encephalitis. J Fujian Med Univ 2018;52:209–10.
    1. XN Z, DW S, LM F, et al. Ovarian teratoma with anti-N-methyl-D-aspartate clinical analysis of five cases of receptor encephalitis. Chin J Obstet Gynecol 2014;49:281–6.
    1. YY G, GD S, HH D. Ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis in 2 cases. Jiangsu Med J 2017;43:205–1207.
    1. Uchida Y, Kato D, Yamashita Y, et al. Failure to improve after ovarian resection could be a marker of recurrent ovarian teratoma in anti-NMDAR encephalitis: a case report. Neuropsychiatr Dis Treat 2018;14:339–42.
    1. Lee KW, Liou LM, Wu MN. Fulminant course in a patient with anti-N-methyl-D-aspartate receptor encephalitis with bilateral ovarian teratomas: a case report and literature review. Medicine (Baltimore) 2018;97:e0339.
    1. Thomas L, Mailles A, Desestret V, et al. Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis. J Infect 2014;68:419–25.
    1. Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis in psychiatry. Curr Psychiatry Rev 2011;7:189–93.
    1. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504–11.
    1. Bacchi S, Franke K, Wewegama D, et al. Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci 2018;52:54–9.
    1. Peer M, Pruss H, Ben-Dayan I, et al. Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 2017;4:768–74.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel